Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Status:
Withdrawn
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment
of patients with visual impairment due to diabetic macular edema (DME).